Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug

• Status: Unknown status
• Trial end date: 2015-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Conelations With Voiding Diary, King's Health Quentionaire, Overactive Bladder Sympton Scores and Patient Perception of Bladder Condition.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Taiwan University Hospital
• Treatments: Muscarinic Antagonists; Solifenacin Succinate

Criteria

Inclusion Criteria:

• female patients within 18 years old to 99 years old with overactive bladder syndrome

Exclusion Criteria:

• unwilling or unable to perform testing procedure